Protagonist Therapeutics (PTGX) – Hot Comments
-
Jefferies Assumes Protagonist Therapeutics (PTGX) at Buy, Sees 59% Upside
-
JPMorgan on Protagonist Therapeutics (PTGX) Following Earlier Data: 'we believe PTGX’s current valuation is attractively positioned'
-
-
-
-
-
Back to PTGX Stock Lookup